4//SEC Filing
Omthera Pharmaceuticals, Inc. 4
Accession 0001179110-13-011898
CIK 0001477598operating
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 1:47 PM ET
Size
5.9 KB
Accession
0001179110-13-011898
Insider Transaction Report
Form 4
Seghezzi Graziano
Director
Transactions
- Disposition to Issuer
Common Stock
2013-07-18−0→ 0 total(indirect: See footnote)
Footnotes (3)
- [F1]Consists of 7,159,317 shares of common stock of Omthera Pharmaceuticals, Inc. (the "Company") held by Sofinnova Capital VI FCPR ("Sofinnova").
- [F2]Pursuant to the Agreement and Plan of Merger by and among the Company, Zeneca, Inc. and KAFA Acquisition Corp., dated May 27, 2013, each share of the Company's common stock was exchanged for $12.70 in cash, without interest, less any applicable withholding taxes, plus one contractual contingent value right, which represents the right to receive contingent payments of up to approximately $4.70 in cash in the aggregate, without interest, less any applicable withholding taxes, if specified milestones are achieved within agreed upon time periods.
- [F3]The shares of the Company's common stock are held directly by Sofinnova. The reporting person is a partner of Sofinnova Partners SAS, which is the managing company of Sofinnova. The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, therein, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Omthera Pharmaceuticals, Inc.
CIK 0001477598
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001477598
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 1:47 PM ET
- Size
- 5.9 KB